Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

April 5, 2010
Halozyme Therapeutics and Avid Bioservices have expanded their commercial supply agreements and entered a long-term strategic relationship.   Read More »
April 1, 2010
Ricerca to reach Asian markets with development pact.   Read More »
March 31, 2010
GlaxoSmithKline and Isis Pharmaceuticals have entered a strategic alliance that will apply Isis’ antisense drug discovery platform to develop new therapeutics against targets for rare and infectious diseases.   Read More »
March 26, 2010
Thermo Fisher Scientific, Inc. and Eli Lilly and Co. have expanded their clinical trial materials supply chain relationship.   Read More »
March 24, 2010
New alliance focuses on biobanking, biorepository needs   Read More »
March 23, 2010
Alnylam succeeds in RNAi tech transfer   Read More »
March 19, 2010
Syringe filters to be included with dissolution testing systems.   Read More »
March 18, 2010
PPD and Southern Research Institute have entered into a collaborative agreement for pandemic and seasonal influenza vaccine R&D in an effort to provide clients with a full spectrum of vaccine development services.   Read More »
March 17, 2010
First pact between the companies will evaluate SNALP's delivery of siRNA molecules.   Read More »
March 9, 2010
Lonza and Odyssey Thera, Inc. have signed an agreement under which Lonza will make Odyssey's Protein-fragment Complementation Assay (PCA) technology, as part of compound profiling services available to life science researchers.   Read More »
March 5, 2010
Xcellerex, Inc. and Humacyte, Inc. have entered into a strategic collaboration under which Xcellerex will develop a manufacturing process enabling the production of Humacyte’s lead regenerative drug product using its XDR single-use bioreactor system   Read More »
March 3, 2010
ADC collaboration bears fruit for Genentech with IND   Read More »
March 3, 2010
Lilly gets $1 million, keeps option to reacquire   Read More »
March 3, 2010
BMS, Allergan to co-develop Phase II-ready neuropathic pain compound   Read More »
March 2, 2010
WuXi and J&JPRD have established a preclinical services and training agreement   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On